Taiwan · Delayed Price · Currency is TWD G&E Herbal Biotechnology Statistics
Total Valuation
TPEX:4911 has a market cap or net worth of TWD 2.02 billion. The enterprise value is 1.60 billion.
| Market Cap | 2.02B |
| Enterprise Value | 1.60B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | Jul 29, 2025 |
Share Statistics
TPEX:4911 has 63.72 million shares outstanding. The number of shares has decreased by -0.15% in one year.
| Current Share Class | 63.72M |
| Shares Outstanding | 63.72M |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | 25.32% |
| Owned by Institutions (%) | n/a |
| Float | 47.59M |
Valuation Ratios
The trailing PE ratio is 17.21.
| PE Ratio | 17.21 |
| Forward PE | n/a |
| PS Ratio | 7.75 |
| PB Ratio | 2.15 |
| P/TBV Ratio | 2.50 |
| P/FCF Ratio | 267.75 |
| P/OCF Ratio | 178.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.49, with an EV/FCF ratio of 212.02.
| EV / Earnings | 13.63 |
| EV / Sales | 6.13 |
| EV / EBITDA | 12.49 |
| EV / EBIT | 13.60 |
| EV / FCF | 212.02 |
Financial Position
The company has a current ratio of 12.07, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.07 |
| Quick Ratio | 11.32 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.09 |
| Interest Coverage | 4,908.75 |
Financial Efficiency
Return on equity (ROE) is 12.97% and return on invested capital (ROIC) is 21.90%.
| Return on Equity (ROE) | 12.97% |
| Return on Assets (ROA) | 7.40% |
| Return on Invested Capital (ROIC) | 21.90% |
| Return on Capital Employed (ROCE) | 12.49% |
| Weighted Average Cost of Capital (WACC) | 0.73% |
| Revenue Per Employee | 6.07M |
| Profits Per Employee | 2.73M |
| Employee Count | 43 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 1.66 |
Taxes
In the past 12 months, TPEX:4911 has paid 6.35 million in taxes.
| Income Tax | 6.35M |
| Effective Tax Rate | 5.13% |
Stock Price Statistics
The stock price has decreased by -37.31% in the last 52 weeks. The beta is -0.64, so TPEX:4911's price volatility has been lower than the market average.
| Beta (5Y) | -0.64 |
| 52-Week Price Change | -37.31% |
| 50-Day Moving Average | 34.89 |
| 200-Day Moving Average | 43.35 |
| Relative Strength Index (RSI) | 36.68 |
| Average Volume (20 Days) | 41,017 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4911 had revenue of TWD 261.21 million and earned 117.55 million in profits. Earnings per share was 1.84.
| Revenue | 261.21M |
| Gross Profit | 217.46M |
| Operating Income | 117.81M |
| Pretax Income | 123.90M |
| Net Income | 117.55M |
| EBITDA | 127.58M |
| EBIT | 117.81M |
| Earnings Per Share (EPS) | 1.84 |
Balance Sheet
The company has 421.70 million in cash and 646,000 in debt, with a net cash position of 421.06 million or 6.61 per share.
| Cash & Cash Equivalents | 421.70M |
| Total Debt | 646,000 |
| Net Cash | 421.06M |
| Net Cash Per Share | 6.61 |
| Equity (Book Value) | 942.96M |
| Book Value Per Share | 14.80 |
| Working Capital | 434.60M |
Cash Flow
In the last 12 months, operating cash flow was 11.31 million and capital expenditures -3.75 million, giving a free cash flow of 7.56 million.
| Operating Cash Flow | 11.31M |
| Capital Expenditures | -3.75M |
| Depreciation & Amortization | 9.77M |
| Net Borrowing | -883,000 |
| Free Cash Flow | 7.56M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 83.25%, with operating and profit margins of 45.10% and 45.00%.
| Gross Margin | 83.25% |
| Operating Margin | 45.10% |
| Pretax Margin | 47.43% |
| Profit Margin | 45.00% |
| EBITDA Margin | 48.84% |
| EBIT Margin | 45.10% |
| FCF Margin | 2.89% |
Dividends & Yields
This stock pays an annual dividend of 1.17, which amounts to a dividend yield of 3.67%.
| Dividend Per Share | 1.17 |
| Dividend Yield | 3.67% |
| Dividend Growth (YoY) | 43.24% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 37.99% |
| Buyback Yield | 0.15% |
| Shareholder Yield | 3.83% |
| Earnings Yield | 5.81% |
| FCF Yield | 0.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 29, 2025. It was a forward split with a ratio of 1.08.
| Last Split Date | Jul 29, 2025 |
| Split Type | Forward |
| Split Ratio | 1.08 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |